↓ Skip to main content

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update

Overview of attention for article published in Clinical Pharmacology & Therapeutics, July 2015
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
78 Dimensions

Readers on

mendeley
61 Mendeley
Title
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update
Published in
Clinical Pharmacology & Therapeutics, July 2015
DOI 10.1002/cpt.161
Pubmed ID
Authors

Y Saito, LK Stamp, KE Caudle, MS Hershfield, EM McDonagh, JT Callaghan, W Tassaneeyakul, T Mushiroda, N Kamatani, BR Goldspiel, EJ Phillips, TE Klein, MTM Lee

Abstract

The Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for HLA-B*58:01 Genotype and Allopurinol Dosing was originally published in February 2013. We reviewed recent literature and concluded that none of the evidence would change the therapeutic recommendations in the original guideline; therefore, the original publication remains clinically current. However, we have updated the supplemental material and included additional resources for applying CPIC guidelines into the electronic health record. Up-to-date information can be found at PharmGKB (http://www.pharmgkb.org). This article is protected by copyright. All rights reserved.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 60 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 11 18%
Researcher 11 18%
Student > Bachelor 7 11%
Professor > Associate Professor 6 10%
Student > Master 6 10%
Other 10 16%
Unknown 10 16%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 15 25%
Biochemistry, Genetics and Molecular Biology 11 18%
Medicine and Dentistry 9 15%
Agricultural and Biological Sciences 3 5%
Nursing and Health Professions 3 5%
Other 5 8%
Unknown 15 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 October 2016.
All research outputs
#9,962,068
of 12,444,560 outputs
Outputs from Clinical Pharmacology & Therapeutics
#2,457
of 2,788 outputs
Outputs of similar age
#229,923
of 335,411 outputs
Outputs of similar age from Clinical Pharmacology & Therapeutics
#180
of 190 outputs
Altmetric has tracked 12,444,560 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,788 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one is in the 4th percentile – i.e., 4% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 335,411 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 190 others from the same source and published within six weeks on either side of this one. This one is in the 2nd percentile – i.e., 2% of its contemporaries scored the same or lower than it.